Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Ciegus Ltd Oy logo — Transforming Medication Safety

Ciegus Ltd Oy

Transforming Medication Safety

Founded 2010 Finland Finland 4 employees Seed Total: $150.00K Biopharma, Health Care +1

General Information

Company Name Ciegus Ltd Oy
Founded Year 2010
Location Finland Finland
Employees 4
Industries Biopharma, Health Care, Medical Devices
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Ciegus Ltd Oy. To contact Ciegus Ltd Oy, visit laaketabletti.fi.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Ciegus Ltd Oy compare?

A PDF of Ciegus Ltd Oy and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Ciegus Ltd Oy soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Ciegus Ltd Oy

Ciegus Ltd Oy is a Nordic innovator in medication management and outpatient care for hospitals, health centers, home care, and care homes. The company, founded in 2009 and headquartered in Finland, prides itself on Transforming Medication Safety. Their flagship product, LääkeTabletti - PharmaTablet Service, is a Closed-Loop Medication Management cloud service for health care professionals delivering medications.

The latest milestone for the company was a €150.00K Seed Round investment on 13 April 2015, secured from VisionPlus. Ciegus Ltd Oy operates in the Biopharma and Health Care industries, catering to a crucial healthcare need with innovative solutions."

Business keywords: Medication management, Outpatient care, Cloud service, Healthcare professionals, Patient safety, Drug safety, Medication safety, Closed-Loop Medication Management, Pharmaceutical, Healthcare innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round €150.00K 1
VisionPlus
VisionPlus
13 Apr 2015

Ciegus Ltd Oy Alternatives & Competitors

View All Alternatives
Ciegus Ltd Oy vs
Causalus
Causalus Finland

Causalus develops digital therapeutics services for rational medication. We help you find the safest...

Pre-Seed
11-50 employees
Health Care, Medical Devices
Ciegus Ltd Oy vs
AceAge
AceAge Canada

Karie | Medication made Simple

Grant
22 employees
Health Care, Medical Devices
Ciegus Ltd Oy vs
Evondos Group
Evondos Group Finland

Supporting your independence

Venture round
210 employees
Health Care, Medical Devices
View all alternatives

FAQ About Ciegus Ltd Oy

Transforming Medication Safety
Ciegus Ltd Oy was founded in 2010.
Ciegus Ltd Oy is headquartered in Finland.
Ciegus Ltd Oy operates in Biopharma, Health Care and Medical Devices. Its work centres on Medication management, Outpatient care, Cloud service and Healthcare professionals.
Ciegus Ltd Oy has approximately 4 employees.
Ciegus Ltd Oy has completed 1 funding round, raising a total of $150.00K. The latest funding stage is Seed.
Top alternatives and competitors to Ciegus Ltd Oy include Causalus, AceAge, Evondos Group, Blink Health, EQUASHIELD®. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ciegus Ltd Oy and Causalus are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Ciegus Ltd Oy, https://bouncewatch.com/company/ciegus-ltd-oy, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout